Sort   by:  
 Page size 
TranscriptomicsANALYSIS OF GENE EXPRESSION IN EARLY-STAGE OVARIAN CANCER (2)
Gene expression was analysed in 68 stage I ovarian cancers and 15 borderline samples using microarrays. Tumors were obtained directly at surgery and immediately frozen in liquid nitrogen until analysis. Glass arrays containing 16000 genes were used. Data was interpreted by unsupervised and supervise...
ORGANISM(S): Homo sapiens 
2007-08-25 | E-GEOD-8842 | biostudies-arrayexpress
TranscriptomicsANALYSIS OF GENE EXPRESSION IN EARLY-STAGE OVARIAN CANCER (1)
Gene expression was analysed in 68 stage I ovarian cancers and 15 borderline samples using microarrays. Tumors were obtained directly at surgery and immediately frozen in liquid nitrogen until analysis. Glass arrays containing 16000 genes were used. Data was interpreted by unsupervised and supervise...
ORGANISM(S): Homo sapiens 
2007-08-24 | E-GEOD-8841 | biostudies-arrayexpress
UnknownExtended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma.
Not available
S-EPMC10265611 | biostudies-literature
UnknownAssociation between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial.
Not available
S-EPMC11235028 | biostudies-literature
UnknownEfficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
Not available
S-EPMC8099757 | biostudies-literature
UnknownImplications of Anion Structure on Physicochemical Properties of DBU-Based Protic Ionic Liquids.
Not available
S-EPMC9483912 | biostudies-literature
UnknownUpdated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.
Not available
S-EPMC8436592 | biostudies-literature
UnknownA multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Not available
S-EPMC6343690 | biostudies-literature
UnknownAvelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Not available
S-EPMC6716603 | biostudies-literature
UnknownThe COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.
Not available
S-EPMC9892255 | biostudies-literature
Sort   by:  
 Page size